Impact (REF3a/b)

Impact template (REF3a)

Download template (167K)

All impact case studies

Download all case studies (754K)

Individual case studies

A: Reducing the global burden of stroke by using aspirin and avoiding heparin use in the treatment of acute stroke (64K)

B: Graduated compression stockings do not reduce the risk of post-stroke deep vein thrombosis (64K)

C: Immediate CT scanning in acute stroke improves outcomes for patients and is very cost effective, whereas arteriography and MR scanning are not cost-effective in secondary prevention (62K)

D: The FOOD trials: feeding policies in hospitalised stroke patients influence patient outcomes (69K)

E: Evidence-based identification and cost-effective treatment of depression in cancer patients (57K)

F: Medically unexplained symptoms including chronic fatigue syndrome can be accurately identified and treated. (58K)

G: Diagnostic criteria for human prion disease enable case ascertainment and underpin international policy on prion disease (77K)

H: Identification of transmission risk of variant Creutzfeldt-Jakob disease (vCJD) via blood and blood products defines critical changes to health policy (89K)

I: Defining the scale and demographics of technology-mediated crimes and illegal images of children, leading to new international accord and changes to sentencing guidelines (66K)

J: Thrombolysis for acute ischaemic stroke is effective for a wide range of patients, including those over 80 years, and improves long-term function and quality of life (83K)

K: Invention and commercialisation of Saccadic Vector Optokinetic Perimetry: development of visual-field testing technology and its translation to clinical practice and the marketplace (54K)

L: Enhancing public understanding of human cognition (50K)

M: The Lothian Birth Cohorts: informing and changing policy and public perceptions on what is and is not associated with normal cognitive ageing (68K)